Pharmaceutical PV DIV - FSB
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2DB25D9307
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Task orders
- 31 $93,774 obligated
Award facts
- Opportunity
-
- SPM2DP13R0007 Solicitation number
- Combined order value
- $93,774 Current and potential, with all options
- Last date to order 95% complete
- IDV ceiling <1% used
- $499,999,999.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Defense Logistics Agency (DLA) has awarded DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois, a single-award Indefinite Delivery Contract (IDC) valued at $499,999,999 through November 2026. This IDC, under the SPE2DB program, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military healthcare facilities nationwide. The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories, including injections, tablets, creams, auto-injectors, and specialty medications.
As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated its capability to provide a diverse array of pharmaceutical products to the DLA, including specialized medications such as Xolair, Trikafta, Keytruda, Botox, and Nucala. The IDC allows DLA to issue firm fixed-price delivery orders for these and other prescription drugs and medical supplies to support the healthcare requirements of the Department of Defense. This contract, which is not associated with any specific set-aside designations, leverages DMS Pharmaceutical Group's status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Task orders
Show all 31
Quick answers
Who was awarded contract SPE2DB25D9307?
SPE2DB25D9307 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 13, 2024.
How much is contract SPE2DB25D9307 worth?
Orders under SPE2DB25D9307 have obligated $93,774. SPE2DB25D9307's own ceiling is $499,999,999.
How many orders have been placed under contract SPE2DB25D9307?
31 orders have been placed under SPE2DB25D9307, the latest on November 10, 2025.
Who can order from contract SPE2DB25D9307?
SPE2DB25D9307 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2DB25D9307 competed?
The extent of competition for SPE2DB25D9307 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV